518 related articles for article (PubMed ID: 31873723)
1. Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression.
Girotti MR; Salatino M; Dalotto-Moreno T; Rabinovich GA
J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31873723
[TBL] [Abstract][Full Text] [Related]
2. Galectins: Multitask signaling molecules linking fibroblast, endothelial and immune cell programs in the tumor microenvironment.
Elola MT; Ferragut F; Méndez-Huergo SP; Croci DO; Bracalente C; Rabinovich GA
Cell Immunol; 2018 Nov; 333():34-45. PubMed ID: 29602445
[TBL] [Abstract][Full Text] [Related]
3. The contribution of tumour-derived exosomes to the hallmarks of cancer.
Meehan K; Vella LJ
Crit Rev Clin Lab Sci; 2016; 53(2):121-31. PubMed ID: 26479834
[TBL] [Abstract][Full Text] [Related]
4. The extracellular matrix modulates the hallmarks of cancer.
Pickup MW; Mouw JK; Weaver VM
EMBO Rep; 2014 Dec; 15(12):1243-53. PubMed ID: 25381661
[TBL] [Abstract][Full Text] [Related]
5. [Molecular biological characteristics of cancer].
Kushlinskiĭ NE; Nemtsova MV
Vestn Ross Akad Med Nauk; 2014; (1-2):5-15. PubMed ID: 25055553
[TBL] [Abstract][Full Text] [Related]
6. Reprogramming the tumor metastasis cascade by targeting galectin-driven networks.
Perrotta RM; Bach CA; Salatino M; Rabinovich GA
Biochem J; 2021 Feb; 478(3):597-617. PubMed ID: 33600595
[TBL] [Abstract][Full Text] [Related]
7. Galectins in the tumor endothelium: opportunities for combined cancer therapy.
Thijssen VL; Poirier F; Baum LG; Griffioen AW
Blood; 2007 Oct; 110(8):2819-27. PubMed ID: 17591944
[TBL] [Abstract][Full Text] [Related]
8. Revisiting the hallmarks of cancer: The role of hyaluronan.
Caon I; Bartolini B; Parnigoni A; Caravà E; Moretto P; Viola M; Karousou E; Vigetti D; Passi A
Semin Cancer Biol; 2020 May; 62():9-19. PubMed ID: 31319162
[TBL] [Abstract][Full Text] [Related]
9. Glycans and galectins in prostate cancer biology, angiogenesis and metastasis.
Compagno D; Gentilini LD; Jaworski FM; Pérez IG; Contrufo G; Laderach DJ
Glycobiology; 2014 Oct; 24(10):899-906. PubMed ID: 24939371
[TBL] [Abstract][Full Text] [Related]
10. Melatonin and Cancer Hallmarks.
Talib WH
Molecules; 2018 Feb; 23(3):. PubMed ID: 29495398
[TBL] [Abstract][Full Text] [Related]
11. The future of biology in driving the field of hyperthermia.
Dewhirst MW; Lee CT; Ashcraft KA
Int J Hyperthermia; 2016; 32(1):4-13. PubMed ID: 26850697
[TBL] [Abstract][Full Text] [Related]
12. Vascular galectins: regulators of tumor progression and targets for cancer therapy.
Thijssen VL; Rabinovich GA; Griffioen AW
Cytokine Growth Factor Rev; 2013 Dec; 24(6):547-58. PubMed ID: 23942184
[TBL] [Abstract][Full Text] [Related]
13. Fine-tuning antitumor responses through the control of galectin-glycan interactions: an overview.
Salatino M; Rabinovich GA
Methods Mol Biol; 2011; 677():355-74. PubMed ID: 20941621
[TBL] [Abstract][Full Text] [Related]
14. Signaling by Extracellular Vesicles Advances Cancer Hallmarks.
Kanada M; Bachmann MH; Contag CH
Trends Cancer; 2016 Feb; 2(2):84-94. PubMed ID: 28741553
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy and Inflammatory Cytokine Signalling in Cancer Cells and the Tumour Microenvironment.
Edwardson DW; Parissenti AM; Kovala AT
Adv Exp Med Biol; 2019; 1152():173-215. PubMed ID: 31456184
[TBL] [Abstract][Full Text] [Related]
16. Intracellular galectins in cancer cells: potential new targets for therapy (Review).
Vladoiu MC; Labrie M; St-Pierre Y
Int J Oncol; 2014 Apr; 44(4):1001-14. PubMed ID: 24452506
[TBL] [Abstract][Full Text] [Related]
17. Hallmarks of cancer: the next generation.
Hanahan D; Weinberg RA
Cell; 2011 Mar; 144(5):646-74. PubMed ID: 21376230
[TBL] [Abstract][Full Text] [Related]
18. Impact of ERK5 on the Hallmarks of Cancer.
Stecca B; Rovida E
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30901834
[TBL] [Abstract][Full Text] [Related]
19. The Hallmarks of Cancer from a Redox Perspective.
Hornsveld M; Dansen TB
Antioxid Redox Signal; 2016 Aug; 25(6):300-25. PubMed ID: 27353526
[TBL] [Abstract][Full Text] [Related]
20. Hallmarks of Cancers: Primary Antibody Deficiency
Abolhassani H; Wang Y; Hammarström L; Pan-Hammarström Q
Front Immunol; 2021; 12():720025. PubMed ID: 34484227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
